These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 23992923)

  • 21. COMT genotype predicts longitudinal cognitive decline and psychosis in 22q11.2 deletion syndrome.
    Gothelf D; Eliez S; Thompson T; Hinard C; Penniman L; Feinstein C; Kwon H; Jin S; Jo B; Antonarakis SE; Morris MA; Reiss AL
    Nat Neurosci; 2005 Nov; 8(11):1500-2. PubMed ID: 16234808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of COMT genotype on behavioral symptomatology in the 22q11.2 Deletion Syndrome.
    Bearden CE; Jawad AF; Lynch DR; Monterossso JR; Sokol S; McDonald-McGinn DM; Saitta SC; Harris SE; Moss E; Wang PP; Zackai E; Emanuel BS; Simon TJ
    Child Neuropsychol; 2005 Feb; 11(1):109-17. PubMed ID: 15846854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The feasibility and safety of S-adenosyl-L-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial.
    Green T; Steingart L; Frisch A; Zarchi O; Weizman A; Gothelf D
    J Neural Transm (Vienna); 2012 Nov; 119(11):1417-23. PubMed ID: 22678699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal study of premorbid adjustment in 22q11.2 deletion (velocardiofacial) syndrome and association with psychosis.
    Radoeva PD; Fremont W; Antshel KM; Kates WR
    Dev Psychopathol; 2017 Feb; 29(1):93-106. PubMed ID: 26864886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lack of influence of COMT Val158Met genotype on cognition in first-episode non-affective psychosis.
    Mata I; Perez-Iglesias R; Pelayo-Teran JM; Rodríguez-Sanchez JM; Gonzalez-Blanch C; Carrasco-Marin E; Vazquez-Barquero JL; Crespo-Facorro B
    Schizophr Res; 2008 Jul; 102(1-3):206-9. PubMed ID: 18407467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
    Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
    Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
    Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
    J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?
    Vergaelen E; Schiweck C; Van Steeland K; Counotte J; Veling W; Swillen A; Drexhage H; Claes S
    Brain Behav Immun; 2018 May; 70():88-95. PubMed ID: 29567371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
    Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
    J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
    Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
    BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.
    Sweet RA; Devlin B; Pollock BG; Sukonick DL; Kastango KB; Bacanu SA; Chowdari KV; DeKosky ST; Ferrell RE
    Mol Psychiatry; 2005 Nov; 10(11):1026-36. PubMed ID: 16027741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome.
    Shashi V; Keshavan MS; Howard TD; Berry MN; Basehore MJ; Lewandowski E; Kwapil TR
    Clin Genet; 2006 Mar; 69(3):234-8. PubMed ID: 16542388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of hyperprolinemia in cognitive and psychiatric features of the 22q11 deletion syndrome.
    Raux G; Bumsel E; Hecketsweiler B; van Amelsvoort T; Zinkstok J; Manouvrier-Hanu S; Fantini C; Brévière GM; Di Rosa G; Pustorino G; Vogels A; Swillen A; Legallic S; Bou J; Opolczynski G; Drouin-Garraud V; Lemarchand M; Philip N; Gérard-Desplanches A; Carlier M; Philippe A; Nolen MC; Heron D; Sarda P; Lacombe D; Coizet C; Alembik Y; Layet V; Afenjar A; Hannequin D; Demily C; Petit M; Thibaut F; Frebourg T; Campion D
    Hum Mol Genet; 2007 Jan; 16(1):83-91. PubMed ID: 17135275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Striatal dopamine release and impaired reinforcement learning in adults with 22q11.2 deletion syndrome.
    van Duin EDA; Kasanova Z; Hernaus D; Ceccarini J; Heinzel A; Mottaghy F; Mohammadkhani-Shali S; Winz O; Frank M; Beck MCH; Booij J; Myin-Germeys I; van Amelsvoort T
    Eur Neuropsychopharmacol; 2018 Jun; 28(6):732-742. PubMed ID: 29703646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of gender and catechol O-methyltransferase (COMT) Val108/158Met polymorphism on emotion regulation in velo-cardio-facial syndrome (22q11.2 deletion syndrome): An fMRI study.
    Coman IL; Gnirke MH; Middleton FA; Antshel KM; Fremont W; Higgins AM; Shprintzen RJ; Kates WR
    Neuroimage; 2010 Nov; 53(3):1043-50. PubMed ID: 20123031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that the COMT(Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study.
    van Winkel R; Henquet C; Rosa A; Papiol S; Fananás L; De Hert M; Peuskens J; van Os J; Myin-Germeys I
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jan; 147B(1):10-7. PubMed ID: 17525974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Catechol-O-methyl transferase and expression of schizophrenia in 73 adults with 22q11 deletion syndrome.
    Bassett AS; Caluseriu O; Weksberg R; Young DA; Chow EW
    Biol Psychiatry; 2007 May; 61(10):1135-40. PubMed ID: 17217925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the 22q11.2 deletion syndrome and its relevance to schizophrenia.
    Van L; Boot E; Bassett AS
    Curr Opin Psychiatry; 2017 May; 30(3):191-196. PubMed ID: 28230630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prodromal symptoms in adolescents with 22q11.2 deletion syndrome and schizotypal personality disorder.
    Shapiro DI; Cubells JF; Ousley OY; Rockers K; Walker EF
    Schizophr Res; 2011 Jun; 129(1):20-8. PubMed ID: 21507614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.